J. D. Easton

Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial

S. Johnston, C. Molina, G. Albers, 2019, Stroke.

New opportunities to optimize antithrombotic therapy for secondary stroke prevention

J. Easton, A. Kim, Anthony S Kim, 2019, International journal of stroke : official journal of the International Stroke Society.

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

P. Amarenco, P. Teal, Ralph L. Sacco, 2008, Chest.

Antithrombotic and thrombolytic therapy for ischemic stroke.

P. Amarenco, P. Teal, Gregory W. Albers, 1998, Chest.

Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial.

H. Lutsep, S. Johnston, A. Lindblad, 2019, Circulation.

Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial

S. Johnston, C. Molina, G. Albers, 2019, International journal of stroke : official journal of the International Stroke Society.

Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial

S. Kasner, S. Johnston, C. Molina, 2018, Stroke.

Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source

S. Kasner, P. Amarenco, Yongjun Wang, 2017, Stroke.

Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Eric E. Adelman, S. Johnston, A. Lindblad, 2019, JAMA network open.